Pediatrix Medical Group, Inc.
Company Stats
- Market Cap
- $2.1B
- as of Sep 30, 2026
- Enterprise Value
- $2.3B
- Shares Outstanding
- 81.3M
- Free Float
- 94.1%
Income Statement
- Revenue
- $1.9B
- Operating Income
- $208.8M
- Net Income
- $165.4M
- EBITDA
- $230.6M
- Revenue Growth, 3Y
- -1.0%
- FCF Margin, 3Y Avg
- 9.2%
- FCF Margin, Worst Year
- 5.2%
Cash Flow
- Free Cash Flow
- $252.6M
- FCF Yield
- 12.1%
- Owner FCF Yield
- 11.2%
Balance Sheet
- Cash & Equivalents
- $375.2M
- Total Debt
- $596.9M
- Net Debt
- $221.6M
- Net Debt / EBITDA
- 0.96x
- EV / EBITDA
- 10.03x
- Net Debt / EBIT
- 1.06x
Returns & Capital
- Share Repurchases
- $86.7M
- Buyback Yield, 3Y Avg
- 1.4%
- SBC, 3Y Avg
- $14.1M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $1.9B | $252.6M | 13.2% |
| FY2024 | $2.0B | $184.6M | 9.2% |
| FY2023 | $2.0B | $104.0M | 5.2% |
| FY2022 | $2.0B | $137.2M | 7.0% |
| FY2021 | $1.9B | $44.5M | 2.3% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 25, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges
Healthcare Earnings: Demand Surges, Costs Bite Back